Neoadjuvant chemotherapy and local radiotherapy for high-grade osteosarcoma of the extremities

Mayo Clinic Proceedings

Volumn 78, Issue 2, 2003, Pages 147-155

  Machak, Gennady N ^a   Tkachev, Sergey I ^a   Solovyev, Yuriy N ^a   Sinyukov, Pavel A ^a   Ivanov, Stanislav M ^a   Kochergina, Natalya V ^a   Ryjkov, Alexey D ^a   Tepliakov, Valery V ^a   Bokhian, Benjamin Y ^a   Glebovskaya, Valeria V ^a  

^a N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE;

ADJUVANT CHEMOTHERAPY; ADOLESCENT; ADULT; ARTICLE; BEAM THERAPY; CANCER CONTROL; CANCER GRADING; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SCINTISCANNING; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; MALE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; OUTCOMES RESEARCH; RADIATION DOSE; SCORING SYSTEM;

EID: 0037310338     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/78.2.147     Document Type: Article

References (42)

1. Bacci G, Ferrari S, Bertoni F, et al. Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the Istituto Ortopedico Rizzoli according to the Istituto Ortopedico Rizzoli/osteosarcoma-2 protocol: an updated report. J Clin Oncol. 2000;18:4016-4027.
2. Bielack S, Kempf-Bielack B, Schwenzer D, et al. Neoadjuvant therapy for localized osteosarcoma of extremities: results from the Cooperative osteosarcoma study group COSS of 925 patients [in German]. Klin Padiatr. 1999;211:260-270.
3. Ferguson WS, Goorin AM. Current treatment of osteosarcoma. Cancer Invest. 2001;19:292-315.
4. Provisor AJ, Ettinger LJ, Nachman JB, et al. Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group. J Clin Oncol. 1997;15:76-84.
5. Weis LD. The success of limb-salvage surgery in the adolescent patient with osteogenic sarcoma. Adolesc Med. 1999;10:451-458.
6. Lindner NJ, Ramm O, Hillmann A, et al. Limb salvage and outcome of osteosarcoma: the University of Muenster experience. Clin Orthop. 1999;358:83-89.
7. Meyers PA, Gorlick R, Heller G, et al. Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol. J Clin Oncol. 1998;16:2452-2458.
8. Bacci G, Picci P, Ferrari S, et al. Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities: results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin. Cancer. 1993;72:3227-3238.
9. Eckardt JJ, Kabo JM, Kelley CM, et al. Expandable endoprosthesis reconstruction in skeletally immature patients with tumors. Clin Orthop. 2000;373:51-61.
10. Hornicek FJ, Gebhardt MC, Tomford WW, et al. Factors affecting nonunion of the allograft-host junction. Clin Orthop. 2001;382:87-98.
11. Renard AJ, Veth RP, Schreuder HW, van Loon CJ, Koops HS, van Horn JR. Function and complications after ablative and limb-salvage therapy in lower extremity sarcoma of bone. J Surg Oncol. 2000;73:198-205.
12. Jaffe N, Wallace S, Carrasco HC, et al. Pediatric osteosarcoma: can cure be achieved with chemotherapy (only) and elimination of surgery? [abstract]. Program Proc Am Soc Clin Oncol. 1993;12:420. Abstract 1443.
13. Cade S. Osteogenic sarcoma: a study based on 133 patients. J R Coll Surg Edinb. 1955-1956;1:79-111.
14. Beck JC, Wara WM, Bovill EG Jr, Phillips TL. The role of radiation therapy in the treatment of osteosarcoma. Radiology. 1976;120:163-165.
15. de Moor NG. Osteosarcoma: a review of 72 cases treated by megavoltage radiation therapy, with or without surgery. S Afr J Surg. 1975;13:137-146.
16. Jenkin RD, Allt W, Fitzpatrick PJ. Osteosarcoma: an assessment of management with particular reference to primary irradiation and selective delayed amputation. Cancer. 1972;2:393-400.
17. Caceres E, Zaharia M, Valdivia S, et al. Local control of osteogenic sarcoma by radiation and chemotherapy. Int J Radiat Oncol Biol Phys. 1984;10:35-39.
18. Carrie C, Breteau N, Negrier S, et al. The role of fast neutron therapy in unresectable pelvic osteosarcoma: preliminary report. Med Pediatr Oncol. 1994;22:355-357.
19. Eilber FR, Morton DL, Eckardt J, Grant T, Weisenburger T. Limb salvage for skeletal and soft tissue sarcomas: multidisciplinary preoperative therapy. Cancer. 1984;53:2579-2584.
20. Lombardi F, Gandola L, Fossati-Belani F, Gianni MC, Rottoli L, Gasparini M. Hypofractionated accelerated radiotherapy in osteogenic sarcoma. Int J Radiat Oncol Biol Phys. 1992;24:761-765.
21. Withrow SJ, Thrall DE, Straw RC, et al. Intra-arterial cisplatin with or without radiation in limb-sparing for canine osteosarcoma. Cancer. 1993;71:2484-2490.
22. Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard DJ. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop. 1993;286:241-246.
23. Deutsch SD, Gandsman EJ, Spraragen SC. Quantitative regional blood-flow analysis and its clinical application during routine bone-scanning. J Bone Joint Surg Am. 1981;63:295-305.
24. Poppe E, Liverud K, Efskind J. Osteosarcoma. Acta Chir Scand. 1968;134:549-556.
25. Gaitan-Yanguas M. A study of the response to osteogenic sarcoma and adjacent normal tissues to radiation. Int J Radiat Oncol Biol Phys. 1981;7:593-595.
26. Goffinet DR, Kaplan HS, Donaldson SS, Bagshaw MA, Wilbur JR. Combined radiosensitizer infusion and irradiation of osteogenic sarcomas. Radiology. 1975;117:211-214.
27. van Putten LM. Tumor reoxygenation during fractionated radiotherapy: studies with a transplantable mouse osteosarcoma. Eur J Cancer. 1968;4:172-182.
28. Weichselbaum R, Little JB, Nove J. Response of human osteosarcoma in vitro to irradiation: evidence for unusual cellular repair activity. Int J Radiat Biol Relat Stud Phys Chem Med. 1977;31:295-299.
29. Kinsella TJ, Glatstein E. Clinical experience with intravenous radiosensitizers in unresectable sarcomas. Cancer. 1987;59:908-915.
30. Martinez A, Goffinet DR, Donaldson SS, Bagshaw MA, Kaplan HS. Intra-arterial infusion of radiosensitizer (BUdR) combined with hypofractionated irradiation and chemotherapy for primary treatment of osteogenic sarcoma. Int J Radiat Oncol Biol Phys. 1985;11:123-128.
31. Picci P, Bacci G, Barbieri E, et al. Persistence of viable tumor in Ewing's sarcoma (ES) after multimodal treatment with primary chemotherapy, radiotherapy, and adjuvant chemotherapy [abstract]. Program Proc Am Soc Clin Oncol. 1998;17:536a. Abstract 2057.
32. Telles NC, Rabson AS, Pomeroy TC. Ewing's sarcoma: an autopsy study. Cancer. 1978;41:2321-2329.
33. Benjamin RS, Patel SR, Armen T, et al. Primary chemotherapy of osteosarcoma of the extremities: long-term follow-up [abstract]. Program Proc Am Soc Clin Oncol. 1993;12:470. Abstract 1639.
34. Souhami RL, Craft AW, Van der Eijken JW, et al. Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup. Lancet. 1997;350:911-917.
35. Rosen G. Preoperative (neoadjuvant) chemotherapy for osteogenic sarcoma: a ten year experience. Orthopedics. 1985;8:659-664.
36. Shapeero LG, Vanel D. Imaging evaluation of the response of high-grade osteosarcoma and Ewing sarcoma to chemotherapy with emphasis on dynamic contrast-enhanced magnetic resonance imaging. Semin Musculoskelet Radiol. 2000;4:137-146.
37. Torricelli P, Montanari N, Spina V, et al. Dynamic contrast enhanced magnetic resonance imaging subtraction in evaluating osteosarcoma response to chemotherapy. Radiol Med (Torino). 2001;101:145-151.
38. van der Woude HJ, Bloem JL, Hogendoorn PC. Preoperative evaluation and monitoring chemotherapy in patients with high-grade osteogenic and Ewing's sarcoma: review of current imaging modalities. Skeletal Radiol. 1998;27:57-71.
39. Edeline V, Frouin F, Bazin JP, et al. Factor analysis as a means of determining response to chemotherapy in patients with osteogenic sarcoma. Eur J Nucl Med. 1993;20:1175-1185.
40. Imbriaco M, Yeh SD, Yeung H, et al. Thallium-201 scintigraphy for the evaluation of tumor response to preoperative chemotherapy in patients with osteosarcoma. Cancer. 1997;80:1507-1512.
41. Rosen G, Loren GJ, Brien EW, et al. Serial thallium-201 scintigraphy in osteosarcoma: correlation with tumor necrosis after preoperative chemotherapy. Clin Orthop. 1993;293:302-306.
42. Bruland OS, Pihl A. On the current management of osteosarcoma: a critical evaluation and a proposal for a modified treatment strategy. Eur J Cancer. 1997;33:1725-1731.